MBI taps Venkatadri as new president

Article

MBI has named Bobba Venkatadri as president and COO, the San Diegoultrasound contrast developer announced last week. Venkatadritakes the place of Vincent Frank, who passed away in August aftera lengthy illness. Venkatadri comes to MBI from monoclonal

MBI has named Bobba Venkatadri as president and COO, the San Diegoultrasound contrast developer announced last week. Venkatadritakes the place of Vincent Frank, who passed away in August aftera lengthy illness.

Venkatadri comes to MBI from monoclonal antibody developerCentocor, where he served as executive vice president of the company'spharmaceutical division. He was instrumental in restructuringCentocor and in building strategic alliances and managing R&D,according to MBI.

In other news, MBI earlier this month said the Federal TradeCommission has cleared its new distribution and investment agreementwith Mallinckrodt Medical (SCAN 9/13/95).

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.